Phosphoglycerate mutase 5 exacerbates cardiac ischemia-reperfusion injury through disrupting mitochondrial quality control
Top Cited Papers
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Redox Biology
- Vol. 38, 101777
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82000537, 81870249, 81900252)
This publication has 74 references indexed in Scilit:
- Targeting cell death in the reperfused heart: Pharmacological approaches for cardioprotectionInternational Journal of Cardiology, 2013
- Myocardial ischemia-reperfusion injury: a neglected therapeutic targetJournal of Clinical Investigation, 2013
- New components of the necroptotic pathwayProtein & Cell, 2012
- Autophagy is impaired in cardiac ischemia-reperfusion injuryAutophagy, 2012
- The Mitochondrial Phosphatase PGAM5 Functions at the Convergence Point of Multiple Necrotic Death PathwaysCell, 2012
- Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosisFree Radical Biology and Medicine, 2011
- The Loss of PGAM5 Suppresses the Mitochondrial Degeneration Caused by Inactivation of PINK1 in DrosophilaPLOS Genetics, 2010
- Mitochondrial phosphoglycerate mutase 5 uses alternate catalytic activity as a protein serine/threonine phosphatase to activate ASK1Proceedings of the National Academy of Sciences, 2009
- PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondriaExperimental Cell Research, 2008
- Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion InjuryPhysiological Reviews, 2008